Cl(-)-ATPase in the CNS is a candidate for an outwardly directed neuronal Cl(-) transporter requiring
phosphatidylinositol-4-phosphate (PI4P) for its optimal activity. To test its pathophysiological changes in a
phosphatidylinositol (PI) metabolism disorder, the effects of neurotoxic factors in
Alzheimer's disease (AD),
amyloid beta proteins (Abetas), on the
Cl(-)-ATPase activity were examined using primary cultured rat hippocampal neurons.
Amyloid beta proteins (1-40, 1-42 and 25-35) concentration-dependently (1-100 nM) and time-dependently (from 1 h to 6 day) decreased
Cl(-)-ATPase activity and elevated intracellular Cl(-) concentrations ([Cl(-)]i),
Abeta25-35 being the most potent. Addition of
inositol or
8-Br-cyclic GMP completely reversed these Abeta-induced changes. The recoveries in
enzyme activity were attenuated by an inhibitor of
PI 4-kinase, 10 microM
wortmannin or 20 microM
quercetin, but not by a
PI 3-kinase inhibitor, 50 nM
wortmannin or 10 microM
LY294002. The PI, PIP and PIP2 levels of the plasma membrane-rich fraction were lower in the Abeta-treated cells as compared with each control. In the Abeta-exposed culture, but not in control, stimulation by 10 microM
glutamate for 10 min significantly increased fragmentation of
DNA and decreased cell viability. Addition of
inositol or
8-Br-cyclic GMP prevented the effect of Abeta-treatment on the neurotoxicity of
glutamate. Thus, Abetas reduce neuronal
Cl(-)-ATPase activity, resulting in an increase in [Cl(-)]i probably by lowering PI4P levels, and this may reflect a pre-apoptotic condition in early pathophysiological profiles of AD.